SC
Samir Chatterjee
About Samir Chatterjee
Data last updated:
Samir Chatterjee is a Director at Chase Life Sciences Private Limited (since 2003). The companies operate in Business Outsourcing and Pharma. Earlier, Samir Chatterjee was a Director at Bewell Labs Private Limited (1999–2019) and Director at Bewell Pharmaceuticals Pvt Ltd (2010–2016).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Feb 2003 | 1992 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 30 Jul 1999 | 1999 | ₹9,990 (FY 2025) | Active | |
| Director | 07 Jan 2010 | 1987 | ₹7,217 (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Samir Chatterjee
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bulbul Chatterjee | 00475174 | Chase Life Sciences Private Limited | Director |
| Sunirmoy Mondal | 00499060 | Chase Life Sciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Samir Chatterjee
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Samir Chatterjee
Samir Chatterjee currently holds 1 directorship: Chase Life Sciences Private Limited (Director, since 01 Feb 2003).
Samir Chatterjee was first appointed on 30 Jul 1999 as Director at Bewell Labs Private Limited. The most recent appointment on record is 07 Jan 2010 at Bewell Pharmaceuticals Pvt Ltd.
Samir Chatterjee held 2 earlier board appointments: Bewell Labs Private Limited (Director, 30 Jul 1999 to 20 Jul 2019); Bewell Pharmaceuticals Pvt Ltd (Director, 07 Jan 2010 to 15 Jun 2016).
The current boards of Samir Chatterjee's companies include Bulbul Chatterjee (Chase Life Sciences Private Limited), Sunirmoy Mondal (Chase Life Sciences Private Limited).